Efficacy and safety of immune checkpoint inhibitor-based regimens for advanced gastric/gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis of randomized controlled trials
Direct head-to-head evidence comparing different immune checkpoint inhibitor (ICI)-based regimens for advanced gastric or gastroesophageal junction adenocarcinoma remains limited. This study aimed to synthesize direct and indirect evidence to evaluate efficacy and safety of relevant immunotherapy regimens and to pr...